Video
Author(s):
Dr. Virgo From American Cancer Society Shares the Results of the PCP/MO Barriers Study
Katherine Virgo, PhD From the American Cancer Society shares the results of the Primary Care Physician and Medical Oncologist Barriers Study.
Nivolumab/CCRT Followed by Nivolumab/Ipilimumab Misses PFS End Point in Select Stage III NSCLC
Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC
Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC
Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab
2 Commerce Drive
Cranbury, NJ 08512